Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
rizatriptan benzoate
Medication labelWhy this: Advisory · dailymed-prescription
MAXALT is indicated for the acute treatment of migraine attacks with or without aura in adults. MAXALT is not intended for the prophylactic therapy of migraine or for use in the management of hemiplegic or basilar migraine (see CONTRAINDICATIONS). Safety and effectiveness of MAXALT have not been established for cluster headache, which is present in an older, predominantly male population.
- generic_name
- rizatriptan benzoate
- product_names
- RIZATRIPTAN BENZOATE
- ndc
- 16590-144, 0006-3800, 16590-144-12, 16590-461, 0006-0267, 16590-461-18
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en